Although oral administration of L-Dopa remains the best therapy for Parkinson disease, its long-term administration causes the appearance of abnormal involuntary movements such as dyskinesia. Although persistent striatal induction of some genes has already been associated with such pathologic profiles in hemiparkinsonian rats, molecular and cellular mechanisms underlying such long-term adaptations remain to be elucidated. In this study, using a rat model of L-Dopainduced dyskinesia, we report that activity regulated cytoskeletal (Arc)-associated protein is strongly upregulated in the lesioned striatum and that the extent of its induction further varies according to the occurrence or absence of locomotor sensitization. Moreover, Arc is preferentially induced, along with FosB, nur77, and homer-1a, in striatonigral neurons, which express mRNA encoding the precursor of dynorphin. Given the likely importance of Arc in the regulation of cytoskeleton during synaptic plasticity, its upregulation supports the hypothesis that a relationship exists between cytoskeletal modifications and the longlasting action of chronically administrated L-Dopa.
INTRODUCTION
Parkinson disease (PD) is a neurologic disorder characterized by an extensive loss of dopaminergic neurons in the substantia nigra pars compacta (1, 2) . The loss of dopamine within the striatum disturbs the functional organization of the basal ganglia networks by causing an imbalance between the 2 efferent striatal output pathways (direct: striatonigral; indirect: striatopallido-subthalamonigral) (3) . Dopamine deficiency causes the motor symptoms of PD such as akinesia, rigidity, and tremor (3, 4) . Despite the intense development of new therapeutic approaches (5), administration of the natural dopamine precursor levodopa (L-Dopa) still remains the best symptomatic treatment (6) . However, its longterm use is commonly associated with side effects such as motor fluctuations and abnormal involuntary movements, namely L-Dopa-induced dyskinesia (LID) (7-10; for review, [11] ). The genesis of LID is not fully understood, but major factors include degree of presynaptic nigral denervation (12) (13) (14) (15) ; onset, dose, and manner of administration of L-Dopa (16) ; sensitization of dopaminergic receptors and their pulsatile stimulation (17, 18) ; imbalance between the output structures of basal ganglia (3, 4) ; as well as alteration of activity and discharge pattern of neurons of basal ganglia (19, 20) . However, the precise mechanisms by which chronic L-Dopa leads to such long-term motor alterations require elucidation.
From experimental studies using animal models of LID (i.e. dopaminergic-lesioned animals chronically treated with L-Dopa given intermittently to simulate dosing schedules in parkinsonian patients), it has been shown that abnormal information storage in the corticostriatal pathways correlates with LID (21) . Moreover, it has been shown that in the striatum, persistent molecular alterations noticeably related to glutamate signaling are involved in LID (22, 23) . Many of these gene modulations are observed in striatonigral-projecting cells of the striatum, suggesting that dynorphin-containing cells may be associated with the development of behavioral sensitization that occurs in animal models of PD after L-Dopa treatment, although the involvement of opioid receptors is still a matter of debate (24) (25) (26) (27) (28) (29) . Often compared with an aberrant form of motor learning (30, 31) , LID might also involve synaptic remodeling. Among the cytoskeleton-related genes, the activityregulated cytoskeletal (Arc)-associated gene is of particular interest. Initially identified in differential screens for seizurestimulated hippocampal mRNA (32, 33) , Arc mRNA rapidly localizes to discrete dendritic regions that have received direct synaptic stimulation (34, 35) . Moreover, Arc is required for long-term potentiation as well as memory in the hippocampus (36) (37) (38) .
In the present study, we asked whether chronic L-Dopa increased the expression of Arc and whether its L-Dopa-driven induction could be correlated with dyskinesia or behavioral sensitization. Using hemiparkinsonian rats that were chronically treated with L-Dopa and developed dyskinetic profiles, we observed that a strong upregulation of Arc at both gene and protein levels, in response to L-Dopa administration in the dopaminergic-depleted striatum, was spatially coincident with that of the FosB-like proteins, homer-1a, nur77 (also known as nerve growth factor-inducible B [NGFI-B]), and preprodynorphin (PPDyn) mRNA levels, in the striatal subregion according to the subtype of motor behavior displayed. Moreover, we observed that Arc is colocalized with PPDyn mRNA in neurons of the direct striatonigral pathway. Finally, we found that L-Dopa-induced motor behavioral response and Arc upregulation are not affected by a modulation of opioid receptor activity. Altogether, these findings highlight a possible involvement of Arc in the development or maintenance of LID and locomotor sensitization and further support a role for cytoskeletal remodeling in the regulation of such long-term motor alterations.
MATERIALS AND METHODS
The animal experimental protocols performed in this study strictly conformed to the guidelines of the French Agriculture and Forestry Ministry and were approved by INSERM.
Lesion Surgery
Male adult Wistar rats, weighing 260 to 300 g, were maintained on a 12-hour light/dark cycle with food and tap water available ad libitum. All animals in this study were anesthetized with chloral hydrate (400 mg/kg) and subjected to unilateral 6-OHDA lesion in the left substantia nigra pars compacta (SNc) using a conventional stereotaxic instrument (David Kopf, Phymep, Paris, France). The lesions were performed according to a standard procedure. Briefly, 12 mg of 6-OHDA-HCl (Sigma, Saint Quentin Fallavier, France) dissolved in 0.1% ascorbate saline were injected in the left SNc at the following coordinates (according to the atlas of Paxinos and Watson (39)) in millimeters and relative to Bregma and cortical surface: A = 5.3; L = 2.1; H = 7.8. To preserve noradrenergic fibers, all animals were intraperitoneally (IP) injected with desipramine-HCl (25 mg/kg; Sigma) at least 30 minutes before 6-OHDA injection.
Amphetamine-Induced Rotational Behavior
Ten to 15 days after lesion, animals were tested for amphetamine-induced rotation. Rats received amphetamine sulfate salt (2.5 mg/kg, IP; Sigma) and were placed in a vertical cylinder. After a period of 30 to 45 minutes, circling behavior was observed for 15 minutes. Only animals showing individual means $5 full turns/minute in the direction ipsilateral to the lesion were selected for the study. This score has been shown to correspond to at least 90% of DA depletion in the striatum (14) . The effectiveness of the lesion was further confirmed postmortem by means of tyrosine hydroxylase (TH) immunohistochemistry and preproenkephalin (PPE) or preprodynorphin (PPDyn) in situ hybridization.
Drug Treatments
All the drugs were purchased from Sigma. Four to 5 weeks after lesion, rats were treated with chronic (twice daily for 10 days) IP injection of physiological saline (lesioned-only animals, n = 3) or L-Dopa (L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride) (50 mg/kg) combined with benserazide hydrochloride (10 mg/kg) (L-Dopa-treated animals, n = 12). Benserazide was given to prevent decarboxylation of L-Dopa in the periphery, as is common in clinical practice. Rats were observed individually after each injection. Another small group of hemiparkinsonian rats (n = 3) were treated for a 3-week period with lower doses of L-Dopa (10 mg/kg) and benserazide (2 mg/kg). For pharmacologic studies, 4 groups of hemiparkinsonian rats (n = 12) were treated with L-Dopa (at 50 mg/kg plus benserazide at 10 mg/kg) twice daily for 10 days as follows: administration of L-Dopa alone, coadministration of L-Dopa plus naloxone dihydrochloride (at 10 mg/kg), coadministration of L-Dopa plus U-50,488H (trans-3,4-di-chloro-N-methyl-N[2]-[(1-pyrrolidinyl) cyclohexyl] benzeneacetamide methane-sulfonate salt) (at 1 mg/kg), and administration of L-Dopa plus an acute injection of nor-binaltorphimine di-hydrochloride (20 mg/kg) 1 hour before L-Dopa on the last day of treatment.
Motor Behavior Analysis
Briefly, individual rats were observed daily in their home cage 1 hour after the injection, when the response to L-Dopa was maximal. Movements were considered as dyskinetic when both of the following criteria were fulfilled: induction by L-Dopa of repetitive and abnormal movements of the body contralateral to the lesion. Abnormal involuntary movements were subdivided into 3 subtypes: forelimb dyskinesia, orolingual dyskinesia, and axial dyskinesia (40) . The severity of each dyskinesia subtype was evaluated for each animal by assigning a rating scale (0-4) (14, 41) . Locomotor sensitization was also evaluated by counting the number of contralateral rotations per minute. Finally, animals were videotaped during the treatment and before death.
Tissue Preparation
Two or 24 hours after the last L-Dopa injection, animals received a lethal dose of chloral hydrate and were killed by intracardiac perfusion of RingerÕs solution followed by 4% paraformaldehyde in 0.1 M Na 2 HPO 4 /NaH 2 PO 4 buffer, pH 7.5 (phosphate buffer). Brains were removed and postfixed in the same fixative solution for 2 hours, washed overnight in 0.1 M phosphate buffer containing 15% sucrose, and then frozen. Rostrocaudal series of coronal sections (20 mm) were cut on a cryostat and then kept in a solution containing 30% ethylene glycol, 30% glycerol, 0.1 M phosphate buffer, and 0.1% diethyl pyrocarbonate (DEPC) at 20°C until they were processed for either in situ hybridization or immunohistochemistry.
In Situ Hybridization
The antisense probes used in this study were a[
35
-S]UTP radiolabeled riboprobes. Preproenkephalin and homer-1a cDNAs were linearized after Apa I digestion and transcribed with SP6 RNA polymerase. The preprodynorphin and Arc antisense probes were linearized after EcoR I digestion and transcribed with T7 RNA polymerase. The nur77 (NGFI-B) antisense probe was linearized with BamH I and transcribed with T3 (42) . Transcription reaction contained 6 mL a[ 15 minutes, the labeled RNA was purified on microspin G50 columns (Amersham Biosciences). Free-floating sections were mounted on SuperFrost Plus slides in RNase-free conditions. Once the sections were dried, in situ hybridization was performed at 60°C in humid chambers for 16 hours according to the previous protocol (43) . After coverslips were removed in 4 3 SSC and 10 mM DTT, the slides were washed in the same solution for 1 hour at room temperature and then in 50% formamide, 10 mM Tris-HCl, pH 8, 75 mM NaCl, and 2.5 mM EDTA. Sections were treated with RNase A (20 mg/mL; Sigma) in 400 mM NaCl, 10 mM Tris-HCl, pH 7.5, and 50 mM EDTA for 30 minutes at 37°C and then were rinsed for 15 minutes at 60°C in 2 3 SSC followed by 0.1 3 SSC. After dehydration, the sections were air-dried and exposed with Biomax-MR films (Kodak).
Immunohistochemistry
Free-floating sections were rinsed in Tris-buffered saline (TBS; 0.25M Tris and 0.25M NaCl, pH 7.5), incubated 5 minutes in TBS containing 3% H 2 O 2 and 10% methanol, and then rinsed 3 times for 10 minutes each in TBS. After 15-minute incubation in 0.2% triton X-100 in TBS, the sections were rinsed 3 times in TBS. These were incubated with the primary antibody (anti-FosB 1/400 rabbit polyclonal H-75 [SC-7203] from Tebu-Bio, Le Parray en Yvelines, France), anti-TH 1/2000 rabbit polyclonal from Jacques Boy (Reims, France), or anti-Arc 1/300 mouse monoclonal from BD Biosciences (Pont de Claix, France) for 72 hours at 4°C. After 3 rinses in TBS, the sections were then incubated 2 hours at 4°C with the corresponding secondary biotinylated antibody in TBS. After being washed, the sections were incubated 90 minutes at room temperature in avidin-biotin-peroxidase complex (ABC) solution (final dilution, 1/50; Vector Laboratories; ABCYS, Paris, France). The sections were then rinsed 2 times in TBS and 2 times in TB (0.25M Tris, pH 7.5) for 10 minutes each, placed in a solution of TB containing 0.1% 3,3#-diaminobenzidine (DAB; 50 mg/100 mL), and developed by H 2 O 2 addition (0.02%).
Double Labeling Combining Immunohistochemistry and In Situ Hybridization
Free-floating sections were processed for FosB or Arc immunohistochemistry as described previously, except that all buffers used were autoclaved. Sections were mounted on SuperFrost Plus slides in RNase-free conditions and air-dried for at least 60 minutes followed by the indicated in situ hybridization. The slides were then coated with LM-1 emulsion (Amersham Biosciences) and exposed. After development, slides were mounted with Eukitt.
Double In Situ Hybridization
The double in situ hybridization procedure was performed as previously described (42) . Briefly, the proportion of nur77 colocalization with PPE or PPDyn mRNA was evaluated using double in situ hybridization with a [ 35 S]UTPlabeled nur77 probe and a nonradioactive digoxigenin (Dig)-labeled PPE or PPDyn riboprobe. PPE and PPDyn riboprobes were labeled with using the Riboprobe System of Promega (Madison, WI) with the Dig-RNA labeling mix (Roche Diagnostics, Laval, Canada). Double in situ hybridization was performed in the same conditions as for single in situ procedure. The Dig-cRNA probe (approximately 50 ng) was simply added in the same hybridization solution with the radioactive (2 3 10 6 cpm) cRNA probe for nur77. An additional step using a 50% formamide solution in 2 3 SSC FIGURE 1. Characterization of the unilateral 6-hydroxydopamine lesion. (A) Representative photomicrographs of brain sections showing TH immunoreactivity after unilateral 6-OHDA injection (n = 30) (the lesioned side is indicated with an asterisk) in the substantia nigra and ventral tegmental areas (left panels) and striatum (right panels). (B) Quantification of the in situ hybridization signals of preproenkephalin (PPE) and preprodynorphin (PPDyn) mRNA probes in the ipsilateral (ipsi) and contralateral (contra) striatal sides after unilateral 6-OHDA injection. ***, p , 0.001 or **, p , 0.01 when compared with the ipsilateral striatum of unlesioned rats. 6-OHDA, 6-hydroxydopamine; acb, accumbens nucleus; cc, corpus callosum; CPu, caudate-putamen; lv, lateral ventricle; PPDyn, preprodynorphin; PPE, preproenkephalin; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata; TH, tyrosine hydroxylase; VTA, ventral tegmental area.
buffer after hybridization was performed to reduce nonspecific Dig labeling. Detection of Dig-labeled RNA was performed with an anti-Dig antibody conjugated to alkaline phosphatase (Boehringer Mannheim, Laval, Canada) visualized using a nitroblue tetrazolium chloride, 5-bromo-4-chloro-3-indolyl phosphate, and levamisole chromogen solution. Slides were then dipped in LM-1 photographic emulsion (Amersham, Oakville, Ontario, Canada) melted at 42°C, air-dried, and stored in the dark for 12 days at 4°C. The emulsion was developed in D-19 developer and fixed (Kodak, New Haven, CT). Slides were coverslipped using a water-soluble mounting medium (Permafluor; Lipshaw Immunon, Pittsburgh, PA). Single-or double-labeled cells were visualized and manually counted under bright-field illumination with a Zeiss photomicroscope at a magnification of 4003. Cell counts were performed in the lateral part of the striatum on 4 different sections (3 fields per section).
Data Analysis
Tissue sections were examined under light microscope. TH, FosB, and Arc-positive neurons were digitalized at various magnifications with a computerized image analyzer (Analysis; Soft Imaging System, Munster, Germany). Cell counts were performed in the lateral part of the striatum ipsilateral to the SNc lesion (3 fields per section). Cells labeled with PPE, PPDyn, and Arc probes were visualized by the accumulation of silver grains over the soma. Densitometric measurements of mRNA signals were obtained from autoradiograms using the NIH Image J 1.29 software (Wayne Rasband, NIMH) after subtraction of background value. They were performed in the lateral part of the striatum on 4 different sections per rat. Histogram shows mean 6 standard error of mean. Statistical analyses were assessed by analysis of variance with multiple comparisons (Newman-Keuls multiple comparison test). 
RESULTS

Characterization of the Unilateral 6-hydroxydopamine Lesion
The dopaminergic lesion was evaluated postmortem by histochemical analysis (Fig. 1) . A complete loss of TH immunostaining was observed ipsilaterally in both the SNc and the striatum of all animals used in the present study (Fig. 1A) . The levels of denervation were the same in all groups of animals. An analysis of the densitometric measurements of TH immunostaining in both SNc and ventral tegmental area (VTA) did not produce a statistical difference between the 2 groups (data not shown). At the striatal level, mRNA levels encoding PPE (p , 0.001) and PPDyn (p , 0.01) were respectively induced or repressed by the lesion (Fig. 1B) .
Evaluation of L-Dopa-Induced Motor Behavior
The motor behavior of hemiparkinsonian rats was observed and evaluated as described in the ''Materials and Methods'' section. Although rats treated chronically with the vehicle did not show any abnormal motor activity (data not shown), rats treated with high doses of L-Dopa could be subdivided into 2 groups according to their rotational behavior (Fig. 2A) . The first group (group 1, n = 7) developed severe locomotor sensitization over time (linear regression coefficient R 2 = 0.9195, p , 0.001), whereas the second group (group 2, n = 5) displayed almost no locomotor sensitization (R 2 = 0.5363, p = 0.057) despite the fact that they received the same L-dopa regimen and displayed the same levels of denervation. The 3 subtypes of dyskinesia (i.e. forelimb, orolingual, and axial) were also evaluated (Fig. 2B) . For each, a gradual increase of the scores was observed over time (Fig. 2B ), but no further difference was noted between the first and second groups (compare left and right columns for each dyskinesia subtype). The dispersion of the results reflects the variability in the severity of the dyskinesia displayed by each animal. No dyskinesia was observed for vehicle-treated hemiparkinsonian rats (data not shown).
Effect of Chronic L-Dopa Treatment on FosB Expression in the Depleted Striatum Figure 3 shows the effect of chronic L-Dopa treatment on the expression of FosB-like proteins after use of an antibody directed against the N-terminal part of FosB and therefore able to recognize both FosB and its chronic isoforms such as DFosB (44) . As expected, FosB-positive nuclei were detected in the striatum ipsilateral to the lesion in response to chronic L-Dopa administration but not in response to chronic vehicle (compare Fig. 3B and C to A) . Although rats from group 1 displayed a widespread expression of FosB-like proteins in both the lateral and the medial parts of the striatum (Fig.  3B#-B$) , rats from group 2 showed an expression restricted to the lateral part of the striatum (Fig. 3C#-C$) . These results concur with previous data showing that the extent of FosB expression varies according to the subtype of motor behavior developed (40) . Of note, the pattern of induction was not related to the pattern of TH depletion because all animals displayed a complete loss of TH in both lateral and medial parts of the striatum. FosB-like proteins induction in the lesioned striatum is similar at 2 and 24 hours after L-dopa administration (Fig. 3D) for all dyskinetic animals, suggesting that persistent forms of FosB-like proteins have been induced.
Effect of Chronic L-Dopa Treatment on PPDyn, Arc, and homer-1a mRNA Expression in the Depleted Striatum Figure 4 shows the effect of chronic L-Dopa treatment on the striatal levels of mRNA encoding for PPDyn, as well as 2 other markers of synaptic plasticity, namely Arc (34, 35) and homer-1a (45-47) on adjacent brain sections. Two hours after the last L-Dopa injection (Fig. 4) , PPDyn mRNA were strongly upregulated (p , 0.001) in response to L-Dopa compared with vehicle ( Fig. 4A-D) , the extent of its mRNA induction correlating with the occurrence or absence of locomotor sensitization as for FosB-like proteins. Strikingly, both Arc ( Fig. 4E-H ; p , 0.001) and homer-1a ( Fig. 4I-L ; p , 0.001) mRNA were induced in response to L-Dopa in the denervated striatum of dyskinetic rats. Their expressions were also spatially correlated with that of PPDyn and FosB. Whereas PPDyn and Arc mRNA remained upregulated 24 hours after the last L-Dopa injection, homer-1a mRNA returned to basal levels (data not shown).
Identification of the Striatal Cell Type in Which Arc Is Upregulated
The combination of Arc immunohistochemistry with PPDyn in situ hybridization revealed that Arc protein was expressed in PPDyn mRNA-containing neurons (Fig. 6B2) . The quantification of this result was addressed by combining the immunohistochemistry of FosB with the in situ hybridization of PPE, PPDyn, or Arc mRNA (Fig. 5) . Indeed, after unilateral medial forebrain bundle lesion and chronic L-Dopa treatment, FosB is expressed by PPDyn-positive neurons (40) . We addressed this point in our model by using striatal sections from both groups of rats (1 and 2) and found that more than 80% of FosB-positive cells colocalized with PPDyn-positive neurons (Fig. 5A, D) compared with 20% colocalizing with PPE-positive neurons (Fig. 5B, D) . We also observed that 65% of FosB-positive cells expressing Arc mRNA (Fig. 5C, D) showed a preferential Arc expression in PPDyn-positive neurons. The occurrence of locomotor sensitization did not alter colocalization, indicating that dyskinesia and locomotor sensitization are associated with distinct spatial expression of those markers in the striatum in a majority of cells expressing PPDyn in the areas examined. 
Effect of Lower Doses of Chronic L-Dopa on Striatal Gene Regulation
Having shown that the Arc gene (and the protein, data not shown) is upregulated in the denervated striatum in response to high doses of L-Dopa, we further analyzed if its induction could still be evoked in responses to more therapeutic doses of L-Dopa treatment (10 mg/kg) (Fig. 6 ). This point was addressed by immunohistochemistry with an antibody against the Arc protein.
As shown in Figure 6A1 , the Arc protein was strongly induced in the lateral part of the striatum, and the extent of its expression was again spatially coincident with that of PPDyn mRNA (Fig.  6B1 ) detected on the adjacent brain section from a dyskinetic rat (2 of 3 animals treated with low doses of L-Dopa displayed dyskinetic movements without locomotor sensitization, whereas the third rat displayed no motor behavior). Interestingly, nur77 mRNA (48) was also strongly upregulated ( Fig. 6C1, C2 ; p , 0.001) in the same striatal territory (compare Figure 6C1 with A1 and B1). Of note, although 95% of PPDyn-positive cells also express nur77 (Fig. 6C3) , only 35% of PPE-containing neurons express nur77 (Fig. 6C4) . Similar results were obtained regardless of when the animals were killed.
Effect of Coadministration of Naloxone, U-50, 488H, or Nor-Binaltorphimine With L-Dopa on Motor Behavior and Gene Expression
To test the involvement of endogenous opioid dynorphin in the development of dyskinesia and behavioral sensitization, we administered k opioid antagonists (naloxone [49] and nor-binaltorphimine [50] ) or agonist (U-50,488H [51] ) in denervated-rats treated with L-Dopa. At the behavioral level, opioid antagonist or agonist administration did not alter the development of dyskinesia (Fig. 7A) as well as locomotor sensitization (data not shown). Similarly, at the histochemical level, PPDyn (data not shown) and Arc (Fig. 7B) mRNA upregulation in the lesioned striatum remained the same in the presence of opioid antagonists. Gene regulation was still spatially correlated to the L-Dopa-driven motor behavior, that is, either restricted to the lateral part of the striatum or in the whole striatum according to the absence or occurrence (Fig. 7B ) of locomotor sensitization, respectively. Similarly, FosB and Arc proteins were still induced (data not shown). These data suggest that in our model, modulation of k opioid receptors does not alter the mechanisms underlying gene induction or those involved in the development of LID and locomotor sensitization.
DISCUSSION
The main goal of the present study using a rat model of LID was to investigate the effect of chronic L-Dopa treatment on the regulation of Arc mRNA and protein in the dopaminedenervated striatum and on its coordinate expression with striatal neuropeptides belonging to the striatonigral and striatopallidal output pathways. The main finding of our study was that intermittent and chronic L-Dopa led to strong upregulation of Arc mRNA, which is spatially coincident with that of PPDyn, homer-1a, and nur77 mRNA as well as FosBlike proteins, their striatal territories of expression being correlated with the motor behavior developed (i.e. dyskinesia accompanied or not with sensitization of their turning behaviors). Moreover, these biochemical alterations of Arc levels, along with homer-1a and nur77, were preferentially observed in striatonigral neurons of the direct striatal output pathway that express PPDyn mRNA, the precursor of the dynorphin peptide.
Arc mRNA is induced in the striatum by acute cocaine (52, 53) and this effect is inhibited by a D1 antagonist, reserpine treatment, or 6-hydroxydopamine lesion (52) . In the current study, we found that Arc mRNA was upregulated in the striatum after chronic L-Dopa administration, validating previous data obtained by a microarray study (54) . The induction of Arc after a chronic L-Dopa treatment contrasts with the fact that most IEG show reduced induction after chronic exposure to a drug. However, Arc mRNA is also upregulated after chronic cocaine in the frontal cortex (55) and chronic morphine in the striatum (56) . The exact function of Arc is unknown, but its induction and subcellular localization (35) led to the hypothesis of its involvement in cytoskeletal rearrangements during the process of synaptic plasticity. Highly enriched in neuronal dendrites, where it localizes in a distribution that parallels that of F-actin (33) , Arc interacts with cytoskeletal proteins such as MAP-2 (57) and promotes CaM kinase II-dependent neurite extension (58) . The short half-life of Arc mRNA contrasts with its persistent striatal induction and indicates that Arc upregulation is unlikely to result from a direct action of L-Dopa but rather a consequence of a L-Dopa-driven long-term adaptation of the structural and molecular network of the striatum. This hypothesis is further supported by the induction of other structural-and synapticrelated genes unpublished data; and [54] ). Finally, it has been shown that Arc mRNA induction depends on NMDA glutamatergic receptors (59, 60) and is required for long-term potentiation as well as memory process in the hippocampus (36) (37) (38) . It is therefore of particular interest to confront our data with other studies in the striatum showing persistent increases of extracellular glutamate levels (61) and lack of depotentiation after induction of long-term potentiation (21) in dyskinetic rats.
Homer proteins have gained particular attention because they are part of postsynaptic densities and are involved in both the localization and function of type I metabotropic glutamatergic receptors (45) (46) (47) as well as in the coupling of NMDA-binding ionotropic glutamate receptors to metabotropic glutamatergic receptors (62) . The dimerization of long homer proteins can serve to link mGluR receptors to inositol triphosphate receptors and thus link extracellular signals to the release of calcium from intracellular stores. The shorter homer-1a protein can be induced in the brain in response to various stimuli, including long-term potentiation, electroconvulsive shocks, and drugs of abuse (63) (64) (65) . This truncated isoform may serve to competitively interfere with the normal linkage between homer-binding proteins (66) (67) (68) (69) . Given the connection between dopaminergic receptors and calcium (70) , our data showing upregulation of homer-1a in response to chronic L-Dopa further supports a link between intracellular calcium signaling and dyskinesia. However, the more transient character of its induction compared with Arc suggests that distinct mechanisms are involved to underlie the transient expression of dyskinesia or its long-term maintenance through a possible synaptic remodeling process.
Similar to Arc, we found that nur77 was upregulated preferentially in selective dynorphin overexpressing striatal areas. This gene encodes an orphan nuclear receptor closely related to members of the steroid/thyroid hormone receptor family but also acts as an IEG. It is induced in the striatum in response to dopamine denervation (48, 64) and chronic haloperidol (42) . Like Arc, nur77 upregulation after alteration of dopaminergic neurotransmission does not desensitize after chronic haloperidol (42) or L-Dopa (48) treatment. These findings strongly suggest that nur77 along with Arc and homer-1a may contribute to the dopamine-driven behavioral sensitization. Interestingly, nur77 is also modulated in transgenic mice overexpressing presenilin-1 that display memory consolidation deficits (71) . Considering that LID may be assimilated to a pathologic form of learning (21) , it is tempting to speculate that this set of signaling-related genes may participate in the cell reprogramming that generate an abnormal activity of the striatonigral pathway leading to abnormal involuntary movements and behavioral sensitization.
Intermittent treatment with L-Dopa markedly elevated PPDyn mRNA levels in the dopamine-denervated striatum. Dynorphin, the endogenous agonist for the k opioid receptor (72) , is enriched in striatonigral neurons (73, 74 ). An increased stimulation of k receptors distributed on glutamatergic terminals (75) and striatonigral neurons (76) may therefore contribute to the sensitization of dopamine agonist-induced behavioral response. It has been shown that the blockade of opioid transmission allows attenuation of LID in rats (25, 26) . However, a more recent study indicated that opioid antagonist treatment increased LID in a nonhuman primate model of PD (77) . We found that blockade of opioid receptors did not alter the development of dyskinesia or the gene modifications that are associated with it in our rat LID model. This might be the result of the downregulation of kappa opioid-binding sites in the striatum and substantia nigra after chronic L-Dopa (78). Moreover, upregulation of endogenous dynorphin may trigger desensitization and downregulation of opioid receptors, because it is known that opioid receptors desensitize rapidly after opioid administration (79) .
Another striking observation made in this study (besides the perfect topographic superimposition between striatal regions of gene upregulations) is the spatial correlation of gene expression with dyskinesia accompanied (whole striatum) or not (lateral part of the striatum) with locomotor sensitization. This particular pattern of expression have been observed in other studies (40) and is not the result of an incomplete denervation of the striatum because we did not report any significant difference in TH immunoreactivity levels between these experimental groups. Furthermore, the absence of locomotor sensitization was not the result of the fact that rats were tested in their home cages, because placing them in a cylinder did not increase the number of rotations, whatever the group involved. Besides dopaminergic input (80, 81) , the striatum receives major glutamatergic afferents from the cerebral cortex and the thalamus (82) (83) (84) (85) . The cortical and thalamic afferents are topographically organized along its rostrocaudal axis and mainly target the lateral portion of the striatum (86) (87) (88) . Therefore, the lateral and medial parts of the striatum differ in terms of afferent inputs. The similarity between the striatal territory targeted by cortical and thalamic afferents and the selective spatial induction of gene expression in the group of dyskinetic animals that did not show behavioral sensitization suggests that the development of sensitization may be associated with corticothalamostriatal individual vulnerability.
Together, these findings demonstrate that Arc along with homer-1a and nur77 is upregulated in the dynorphincontaining striatonigral neurons from dyskinetic rats support a role for cytoskeletal remodeling in the regulation of L-Dopainduced long-term motor alterations. Further studies are required to elucidate if these molecular changes are responsible for or protective against LID.
